已收盤 11-20 16:00:00 美东时间
0.000
0.00%
11月18日,Zentalis Pharmaceuticals(ZNTL)收跌6.88%,报1.49美元,成交额194.98万美元,市值1.46亿美元。 行情数...
11-18 07:48
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
11月11日,Zentalis Pharmaceuticals(ZNTL)收涨3.45%,报1.8美元,成交额478.28万美元,市值1.7亿美元。 行情数据...
11-11 07:42
Wedbush analyst Robert Driscoll upgrades Zentalis Pharmaceuticals (NASDAQ:ZNTL) from Neutral to Outperform and raises the price target from $5 to $6.
11-10 23:13
Zentalis Pharmaceuticals announced positive survival data from the DENALI Part 1b trial for azenosertib, a potential first-in-class oral therapy for Cyclin E1-positive platinum-resistant ovarian cancer (PROC). DENALI Part 2c enrollment is expected to complete in November 2026, with a topline readout anticipated in the first half of 2027. The company reported $228.9 million in cash as of September 30, 2026, providing runway into the first half of ...
11-09 21:05
11月4日,Zentalis Pharmaceuticals(ZNTL)收跌3.78%,报1.78美元,成交额232.04万美元,市值1.69亿美元。 行情数据...
11-04 07:43
Zentalis Pharmaceuticals announced that its management team will participate in two upcoming investor conferences: Guggenheim's 3rd Annual Healthcare Innovation Conference on November 10, 2026, and Stifel's 2026 Healthcare Conference on November 11, 2026. The company is advancing its first-in-class WEE1 inhibitor, azenosertib, for ovarian cancer treatment. Live webcasts and recordings of the events will be available on the company's website.
11-03 21:15
11月3日,Zentalis Pharmaceuticals(ZNTL)收跌5.61%,报1.85美元,成交额167.32万美元,市值1.75亿美元。 行情数据...
11-03 07:42
Zentalis Pharmaceuticals granted 136,000 non-qualified stock options to four new employees on November 2, 2026, under the 2022 Inducement Plan. The options have an exercise price of $1.85 per share, a 10-year term, and vest over four years, with 25% vesting after the first year and the remaining 75% in equal monthly installments over the following three years. Continued employment is required for vesting. The company focuses on developing ovarian...
11-02 22:00
10月27日,Zentalis Pharmaceuticals(ZNTL)收跌6.33%,报2.07美元,成交额220.69万美元,市值1.96亿美元。 行情数...
10-27 06:41